NEXTMED
DEAD

Serial Number

97685702

Owner

Helio Logistics, Inc.

Attorney

Daniel P. Mullarkey

Filing Date

Nov 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEXTMED Trademark

Serial Number: 97685702

NEXTMED is a trademark filed by Helio Logistics, Inc. on November 21, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Helio Logistics, Inc. (6 trademarks)

2248 Broadway, #1158
New York, NY 10024

Entity Type: 03

Trademark Details

Filing Date

November 21, 2022

Registration Date

Not Registered

Goods & Services

Health assessment services for others through health survey questionnaires, dietetic assessments, pre-exercise assessments, pharmacy prescription assessments and metabolic assessment profiles (MAP) to assist in reaching weight-loss and wellness-related goals; consulting services in the fields of diagnostic medical testing and nutrition; counseling services in the fields of health, nutrition and lifestyle wellness; food nutrition consultation; providing a website featuring information about health, wellness and nutrition; providing healthy lifestyle and nutrition services, namely, personal assessments, personalized routines, maintenance schedules, and counseling; providing information about weight-loss medicine, dietary supplements and nutrition; providing information, news and commentary in the field of nutrition, health and wellness; medical and pharmaceutical consultation; medical clinic providing weight loss solutions, services and programs, nutrition counseling; weight reduction diet planning and supervision; Conducting health care programs to promote lifestyle modifications in nutrition and exercise; concierge weight loss therapy and community-based weight loss programs; chronic care management, namely, remote patient monitoring and continuous glucose monitoring in the nature of remote medical monitoring; anti-aging therapy and services, namely, medical treatment services related to reducing metabolic age; medical services, namely, hormone therapy and treatment, in both men and women; medical services, namely, testosterone and fertility therapy and treatment; medical services, namely, diabetes treatment and services, namely, providing dietary and nutritional guidance for managing diabetes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sep 20, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 20, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 6, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 6, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 7, 2024 GNFN
FINAL REFUSAL E-MAILED
Mar 7, 2024 GNFR
FINAL REFUSAL WRITTEN
Mar 7, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 18, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 18, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 5, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 5, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 5, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2022 NWOS
NEW APPLICATION ENTERED
Nov 24, 2022 NWAP